BioPharmSignal logoBioPharmSignal

Biotech News

Sight Sciences to Present at Two Upcoming Investor Conferences

Sight Sciences (SGHT)Sight SciencesCompany update

MENLO PARK, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today

Related news

SGHTSight Sciences2026-11-05 13:00 EST

Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids

SGHTSight Sciences2026-11-04 21:05 EST

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

TARSTarsus Pharmaceuticals2026-11-05 21:30 EST

Tarsus to Participate in Upcoming Investor Conferences

CVRXCVRx2026-11-02 21:02 EST

CVRx to Participate in Upcoming Investor Conferences

ANGOAngioDynamics2026-10-29 12:00 EST

AngioDynamics to Participate in Upcoming Investor Conferences

OCGNOcugen2026-10-29 11:02 EST

Ocugen to Participate in Upcoming November Investor and Industry Conferences

AORTArtivion2026-10-28 20:10 EST

Artivion to Participate in Upcoming Investor Conferences

LUNGPulmonx2026-10-28 20:05 EST

Pulmonx to Participate in Upcoming Investor Conferences

PRQRProQR Therapeutics2026-10-28 12:00 EST

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

DCTHDelcath Systems2026-10-27 12:30 EST

Delcath Systems to Participate in Upcoming Investor Conferences

View all latest news

Sight Sciences

Interventional Eye Care Sight Sciences develops minimally invasive and noninvasive technologies intended to address underlying causes of glaucoma and dry-eye disease. Glaucoma Systems OMNI and OMNI Edge are implant-free minimally invasive glaucoma-surgery systems that access Schlemm's canal and the trabecular meshwork. SION is a...

Recent company news

SGHTSight Sciences2026-11-05 21:05 EST

Sight Sciences to Present at Two Upcoming Investor Conferences

SGHTSight Sciences2026-11-05 13:00 EST

Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids

SGHTSight Sciences2026-11-04 21:05 EST

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

SGHTSight Sciences2026-10-21 20:05 EST

Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

SGHTSight Sciences2026-10-01 11:05 EST

Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

Stock data

Close
9.76 USD
Market cap
236.14M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States